Catasys, Inc. (“Catasys” or “the Company”) provides specialized health management services to health plans, employers and unions through a network of licensed and company-managed health care providers. Catasys’ integrated substance dependence program, OnTrak, is designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long-term care coaching and online tools to aid members in their recovery.
The Company’s proprietary solution addresses a potential market of 191 million members, with projected revenue of $8.5 million per every one million covered members. With no direct competition and a low threshold of only 1.5 million members needed to reach breakeven, Catasys represents a compelling opportunity for investors.